Atorvastatin withdrawal elicits oxidative/nitrosative damage in the rat cerebral cortex

Pharmacological Research

Volumn 71, Issue , 2013, Pages 1-8

  De Oliveira, Clarissa Vasconcelos ^a   Funck, Vinícius Rafael ^a   Pereira, Letícia Meier ^a   Grigoletto, Jéssica ^a   Rambo, Leonardo Magno ^a   Ribeiro, Leandro Rodrigo ^a   Royes, Luiz Fernando Freire ^a   Furian, Ana Flávia ^a   Oliveira, Mauro Schneider ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Atorvastatin; Cerebral cortex; Nitrosative damage; SOD; Withdrawal

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ATORVASTATIN; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE TRANSFERASE; NITRATE; NITRIC OXIDE; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BRAIN CORTEX; BRAIN DAMAGE; CELL ASSAY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LOCALIZATION; IMMUNOPRECIPITATION; MALE; NEUROCHEMISTRY; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; TREATMENT WITHDRAWAL; UPREGULATION;

ANIMALS; CEREBRAL CORTEX; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; NITRIC OXIDE; OXIDATION-REDUCTION; PYRROLES; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME; SUPEROXIDE DISMUTASE; TYROSINE;

EID: 84876101569     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.02.003     Document Type: Article

References (50)

1. A. Endo A historical perspective on the discovery of statins Proceedings of the Japan Academy-Series B: Physical and Biological Sciences 86 2010 484 493
2. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annual Review of Pharmacology and Toxicology 45 2005 89 118
3. F. Franzoni, A. Quiñones-Galvan, F. Regoli, E. Ferrannini, and F. Galetta A comparative study of the in vitro antioxidant activity of statins International Journal of Cardiology 90 2003 317 321
4. S. Wassmann, U. Laufs, K. Müller, C. Konkol, K. Ahlbory, A.T. Bäumer, W. Linz, M. Böhm, and G. Nickenig Cellular antioxidant effects of atorvastatin in vitro and in vivo Arteriosclerosis, Thrombosis, and Vascular Biology 22 2002 300 305
5. E. Barone, G. Cenini, F. Di Domenico, S. Martin, R. Sultana, C. Mancuso, M.P. Murphy, E. Head, and D.A. Butterfield Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of alzheimer disease: a novel mechanism of action Pharmacological Research 63 2011 172 180
6. D. Lu, A. Goussev, J. Chen, P. Pannu, Y. Li, A. Mahmood, and M. Chopp Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury Journal of Neurotrauma 21 2004 21 32
7. T. Kahles, P. Luedike, M. Endres, H.J. Galla, H. Steinmetz, R. Busse, T. Neumann-Haefelin, and R.P. Brandes Nadph oxidase plays a central role in blood-brain barrier damage in experimental stroke Stroke 38 2007 3000 3006
8. U. Laufs, K. Gertz, P. Huang, G. Nickenig, M. Böhm, U. Dirnagl, and M. Endres Atorvastatin upregulates type iii nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice Stroke 31 2000 2442 2449
9. A. Zacco, J. Togo, K. Spence, A. Ellis, D. Lloyd, S. Furlong, and T. Piser 3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors protect cortical neurons from excitotoxicity Journal of Neuroscience 23 2003 11104 11111
10. V.R. Funck, C.V. de Oliveira, L.M. Pereira, L.M. Rambo, L.R. Ribeiro, L.F. Royes, J. Ferreira, G.P. Guerra, A.F. Furian, M.S. Oliveira, C.A. Mallmann, and C.F. de Mello Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures Epilepsia 52 2011 2094 2104
11. E. Russo, E. Donato di Paola, P. Gareri, A. Siniscalchi, A. Labate, L. Gallelli, R. Citraro, and G. De Sarro Pharmacodynamic potentiation of antiepileptic drugs' effects by some hmg-coa reductase inhibitors against audiogenic seizures in dba/2 mice Pharmacological Research 70 2012 1 12
12. M. Thomas, and J. Mann Increased thrombotic vascular events after change of statin Lancet 352 1998 1830 1831
13. G.C. Fonarow, R.S. Wright, F.A. Spencer, P.D. Fredrick, W. Dong, N. Every, and W.J. French Investigators NRoMI: effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality American Journal of Cardiology 96 2005 611 616
14. C. Vecchione, and R.P. Brandes Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice Circulation Research 91 2002 173 179
15. K. Gertz, U. Laufs, U. Lindauer, G. Nickenig, M. Böhm, U. Dirnagl, and M. Endres Withdrawal of statin treatment abrogates stroke protection in mice Stroke 34 2003 551 557
16. A. Pineda, and L.X. Cubeddu Statin rebound or withdrawal syndrome: does it exist? Current Atherosclerosis Reports 13 2011 23 30
17. U. Laufs, S. Wassmann, S. Hilgers, N. Ribaudo, M. Böhm, and G. Nickenig Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men American Journal of Cardiology 88 2001 1306 1307
18. U. Laufs, M. Endres, F. Custodis, K. Gertz, G. Nickenig, J.K. Liao, and M. Böhm Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho gtpase gene transcription Circulation 102 2000 3104 3110
19. D. Dowlatshahi, A.M. Demchuk, J. Fang, M.K. Kapral, M. Sharma, and E.E. Smith Network RotCS: association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage Stroke 43 2012 1518 1523
20. M.M. Reidenberg Drug discontinuation effects are part of the pharmacology of a drug Journal of Pharmacology and Experimental Therapeutics 339 2011 324 328
21. J.A. Staffa, J. Chang, and L. Green Cerivastatin and reports of fatal rhabdomyolysis New England Journal of Medicine 346 2002 539 540
22. M.J. Cziraky, V.J. Willey, J.M. McKenney, S.A. Kamat, M.D. Fisher, J.R. Guyton, T.A. Jacobson, and M.H. Davidson Statin safety: an assessment using an administrative claims database American Journal of Cardiology 97 2006 61C 68C
23. K.M. Miranda, M.G. Espey, and D.A. Wink A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite Nitric Oxide 5 2001 62 71
24. G. Joshi, M. Perluigi, R. Sultana, R. Agrippino, V. Calabrese, and D.A. Butterfield In vivo protection of synaptosomes by ferulic acid ethyl ester (faee) from oxidative stress mediated by 2,2-azobis(2-amidino-propane) dihydrochloride (aaph) or fe(2+)/h(2)o(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders Neurochemistry International 48 2006 318 327
25. V.J. Thannickal, and B.L. Fanburg Activation of an h2o2-generating nadh oxidase in human lung fibroblasts by transforming growth factor beta 1 Journal of Biological Chemistry 270 1995 30334 30338
26. A. Zanotto-Filho, R. Schröder, and J.C. Moreira Xanthine oxidase-dependent ros production mediates vitamin a pro-oxidant effects in cultured sertoli cells Free Radical Research 42 2008 593 601
27. S.K. Bhattacharya, J.H. Thakar, P.L. Johnson, and D.R. Shanklin Isolation of skeletal muscle mitochondria from hamsters using an ionic medium containing ethylenediaminetetraacetic acid and nagarse Analytical Biochemistry 192 1991 344 349
28. H.P. Misra, and I. Fridovich The generation of superoxide radical during the autoxidation of hemoglobin Journal of Biological Chemistry 247 1972 6960 6962
29. A.F. Furian, M.S. Oliveira, L.F. Royes, N.G. Fiorenza, M.R. Fighera, J.C. Myskiw, R. Weiblen, M.A. Rubin, R. Frussa-Filho, and C.F. Mello Gm1 ganglioside induces vasodilation and increases catalase content in the brain Free Radical Biology and Medicine 43 2007 924 932
30. W.H. Habig, M.J. Pabst, and W.B. Jakoby Glutathione s-transferases: the first enzymatic step in mercapturic acid formation Journal of Biological Chemistry 249 1974 7130 7139
31. L.B. Mamo, H.B. Suliman, B.L. Giles, R.L. Auten, C.A. Piantadosi, and E. Nozik-Grayck Discordant extracellular superoxide dismutase expression and activity in neonatal hyperoxic lung American Journal of Respiratory and Critical Care Medicine 170 2004 313 318
32. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72 1976 248 254
33. L.A. MacMillan-Crow, J.P. Crow, and J.A. Thompson Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues Biochemistry 37 1998 1613 1622
34. F. Yamakura, H. Taka, T. Fujimura, and K. Murayama Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine Journal of Biological Chemistry 273 1998 14085 14089
35. C.Y. Wang, P.Y. Liu, and J.K. Liao Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends in Molecular Medicine 14 2008 37 44
36. Q. Zhou, and J.K. Liao Pleiotropic effects of statins-basic research and clinical perspectives Circulation Journal 74 2010 818 826
37. E. Barone, C. Mancuso, F. Di Domenico, R. Sultana, M.P. Murphy, E. Head, and D.A. Butterfield Biliverdin reductase-a: a novel drug target for atorvastatin in a dog pre-clinical model of alzheimer disease Journal of Neurochemistry 120 2012 135 146
38. D.A. Butterfield, E. Barone, F. Di Domenico, G. Cenini, R. Sultana, M.P. Murphy, C. Mancuso, and E. Head Atorvastatin treatment in a dog preclinical model of alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain International Journal of Neuropsychopharmacology 15 2012 981 987
39. L.X. Cubeddu, and M.J. Seamon Statin withdrawal: clinical implications and molecular mechanisms Pharmacotherapy 26 2006 1288 1296
40. J.R. Steinert, T. Chernova, and I.D. Forsythe Nitric oxide signaling in brain function, dysfunction, and dementia Neuroscientist 16 2010 435 452
41. D.T. Hess, A. Matsumoto, S.O. Kim, H.E. Marshall, and J.S. Stamler Protein s-nitrosylation: purview and parameters Nature Reviews Molecular Cell Biology 6 2005 150 166
42. J.M. Souza, G. Peluffo, and R. Radi Protein tyrosine nitration-functional alteration or just a biomarker? Free Radical Biology and Medicine 45 2008 357 366
43. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochemical Journal 357 2001 593 615
44. P.J. van der Most, A.M. Dolga, I.M. Nijholt, P.G. Luiten, and U.L. Eisel Statins: mechanisms of neuroprotection Progress in Neurobiology 88 2009 64 75
45. G. Ferrer-Sueta, and R. Radi Chemical biology of peroxynitrite: kinetics, diffusion, and radicals ACS Chemical Biology 4 2009 161 177
46. A.K. Holley, S.K. Dhar, and D.K. St Clair Manganese superoxide dismutase vs. P53: regulation of mitochondrial ros Mitochondrion 10 2010 649 661
47. S. Dikalov Cross talk between mitochondria and nadph oxidases Free Radical Biology and Medicine 51 2011 1289 1301
48. A.E. Dikalova, A.T. Bikineyeva, K. Budzyn, R.R. Nazarewicz, L. McCann, W. Lewis, D.G. Harrison, and S.I. Dikalov Therapeutic targeting of mitochondrial superoxide in hypertension Circulation Research 107 2010 106 116
49. A.K. Doughan, D.G. Harrison, and S.I. Dikalov Molecular mechanisms of angiotensin ii-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction Circulation Research 102 2008 488 496
50. W. Guo, T. Adachi, R. Matsui, S. Xu, B. Jiang, M.H. Zou, M. Kirber, W. Lieberthal, and R.A. Cohen Quantitative assessment of tyrosine nitration of manganese superoxide dismutase in angiotensin ii-infused rat kidney American Journal of Physiology-Heart and Circulatory Physiology 285 2003 H1396 H1403